Annual report pursuant to Section 13 and 15(d)

Share-Based Compensation - Summary of Activities Under Share-Based Compensation Plans (Detail)

v3.25.0.1
Share-Based Compensation - Summary of Activities Under Share-Based Compensation Plans (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Outstanding and nonvested as of December 31, 2023, Number of Shares [1] 6,118    
Granted, Number of Shares 5,445    
Vested, Number of Shares (2,626)    
Forfeited, Number of Shares [2] (2,648)    
Outstanding and nonvested as of December 31, 2024, Shares [1] 6,289 6,118  
Number of Shares, Expected to vest, Ending Balance 6,112    
Outstanding and nonvested as of December 31, 2023, Weighted Average Grant Date Fair Value Per Share [1] $ 20.76    
Granted, Weighted Average Grant Date Fair Value Per Share 9.41    
Vested, Weighted Average Grant Date Fair Value Per Share 21.35    
Forfeited, Weighted Average Grant Date Fair Value Per Share [2] 16.32    
Outstanding and nonvested as of December 31, 2024, Weighted Average Grant Date Fair Value Per Share [1] 12.56 $ 20.76  
Expected to vest as of December 31, 2024, Weighted Average Grant Date Fair Value Per Share $ 12.58    
Stock Appreciation Rights (SARs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Awards Outstanding, Beginning Balance [3] 4,340    
Granted, Number of Awards [4] 7,364    
Forfeited/expired, Number of Awards [5] (702)    
Number of Awards Outstanding, Ending Balance [3] 11,002 4,340  
Number of Awards Exercisable, Ending Balance [6] 2,676    
Number of Awards Vested and expected to vest, Ending Balance [7] 7,367    
Weighted Average Exercise Price Per Award Outstanding, Beginning Balance [3] $ 19.85    
Granted, Weighted Average Exercise Price Per Award [4] 8.6    
Forfeited/expired, Weighted Average Exercise Price Per Award [5] 22.97    
Weighted Average Exercise Price Per Award Outstanding, Ending Balance [3] 12.12 $ 19.85  
Exercisable, Weighted Average Exercise Price Per Award, Ending Balance [6] 20.39    
Weighted Average Exercise Price Per Award, Vested and expected to vest, Ending Balance [7] $ 14.04    
Weighted Average Remaining Contractual Term Outstanding [3] 7 years 1 month 6 days 6 years 4 months 24 days  
Exercisable Weighted Average Remaining Contractual Term [6] 4 years 10 months 24 days    
Weighted Average Remaining Contractual Term, Vested and expected to vest [7] 7 years 7 months 6 days    
Aggregate Intrinsic Value Outstanding [3],[8] $ 0.0 $ 2.4  
Exercisable, Aggregate Intrinsic Value [6],[8] 0.0    
Aggregate Intrinsic Value, Vested and expected to vest [7],[8] $ 0.0    
Granted, Weighted Average Grant Date Fair Value Per Share $ 4.61 $ 7.83 $ 6.38
[1] Includes zero and 307,116 performance based stock unit awards as of December 31, 2024 and 2023, respectively, which represents the maximum amount that can vest.
[2] Includes 307,116 performance-based stock unit awards.
[3] Includes 4.0 million and 0.6 million performance condition SARs as of December 31, 2024 and 2023, respectively.
[4] Includes 3.4 million performance condition SARs granted to a consultant.
[5] Includes 0.1 million performance condition SARs.
[6] Includes 0.6 million performance condition SARs.
[7] Includes 0.6 million performance condition SARs.
[8] The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards.